z-logo
open-access-imgOpen Access
An early feasibility study of the Nativis Voyager ® device in patients with recurrent glioblastoma: first cohort in US
Author(s) -
Charles Cobbs,
Edward F. McClay,
J. Paul Duic,
Burt Nabors,
Donna Morgan Murray,
Santosh Kesari
Publication year - 2018
Publication title -
cns oncology
Language(s) - English
Resource type - Journals
eISSN - 2045-0915
pISSN - 2045-0907
DOI - 10.2217/cns-2018-0013
Subject(s) - glioblastoma , medicine , cohort , oncology , cancer research
These data suggest that the Voyager is safe and feasible for the treatment of rGBM.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom